Search - tctmd.com

Displaying 601 - 620 of 1721

Sort: Relevancy | Date

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

Case #3: Recurrent In-stent Restenosis

Presenter: Jeffrey Moses

September 28, 2019

Presentation TCT 2019

Case #2: STEMI PCI In A Newly Diabetic Patient

Presenter: Shamir Mehta

September 28, 2019

Presentation TCT 2019

Case #1: Complex PCI

Presenter: David Wohns, MD

September 28, 2019

Presentation TCT 2019

High-Risk PCI Case Review

Presenter: Kathleen Kearney

September 27, 2019

Presentation TCT 2019

Minority Women Undergoing PCI: Optimizing Outcomes in the New High-Risk PCI Cohort

Presenter: Kelly Epps

September 27, 2019

Presentation TCT 2019

Impella-Assisted PCI: Can This Strategy Prevent AKI in High-Risk Patients?

Presenter: Michael Flaherty

September 27, 2019

Presentation TCT 2019

Case Review: Complex PCI Post-TAVR Implant

Presenter: Anand Prasad

September 27, 2019

Presentation TCT 2019

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS)

Presenter: Rafael Ferreira

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Presentation TCT 2019

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Presenter: Roxana Mehran

September 26, 2019

Advertisement

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Case #3: Recurrent In-stent Restenosis

Case #2: STEMI PCI In A Newly Diabetic Patient

Case #1: Complex PCI

High-Risk PCI Case Review

Minority Women Undergoing PCI: Optimizing Outcomes in the New High-Risk PCI Cohort

Impella-Assisted PCI: Can This Strategy Prevent AKI in High-Risk Patients?

Case Review: Complex PCI Post-TAVR Implant

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS)

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content